| scholarly article | Q13442814 |
| P2093 | author name string | Yao Chen | |
| Chen Wang | |||
| Hanqing Zhao | |||
| Zhonggui He | |||
| Bingjun Sun | |||
| Cong Luo | |||
| Shenwu Zhang | |||
| Weiping Cui | |||
| P2860 | cites work | Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier | Q33601761 |
| Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. | Q51317857 | ||
| Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends. | Q55278614 | ||
| Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles. | Q55431512 | ||
| Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations | Q57100750 | ||
| Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism | Q57122855 | ||
| Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles | Q91251385 | ||
| The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein | Q34235311 | ||
| Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors | Q34307126 | ||
| Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice | Q35178040 | ||
| The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability | Q35620976 | ||
| Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs | Q35744968 | ||
| Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation | Q36119605 | ||
| Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer | Q36371642 | ||
| A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer | Q36611637 | ||
| Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs | Q36748145 | ||
| Quantification of rutin in rat's brain by UHPLC/ESI-Q-TOF-MS/MS after intranasal administration of rutin loaded chitosan nanoparticles. | Q37579343 | ||
| Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). | Q37988960 | ||
| Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy | Q38175767 | ||
| Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead | Q38199539 | ||
| BCS class IV drugs: Highly notorious candidates for formulation development | Q39088924 | ||
| Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. | Q39147455 | ||
| Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel | Q39870809 | ||
| Preclinical evaluation of docetaxel (Taxotere). | Q40519309 | ||
| Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel | Q41283476 | ||
| Docetaxel (taxotere, Rhone-Poulenc Rorer). | Q41495532 | ||
| Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies | Q43280608 | ||
| Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation | Q43285481 | ||
| Pharmacokinetics of oral cyclosporin A when co-administered to enhance the absorption of orally administered docetaxel | Q43731929 | ||
| Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus | Q45014237 | ||
| Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel | Q45030094 | ||
| Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats | Q46044413 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | cyclosporine | Q367700 |
| docetaxel | Q420436 | ||
| lip and oral cavity carcinoma | Q55790434 | ||
| P304 | page(s) | 542-550 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | Drug Delivery | Q5308838 |
| P1476 | title | Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy | |
| P478 | volume | 26 |
Search more.